{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T17:35:30Z","timestamp":1789320930618,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","contactlensjournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contact Lens and Anterior Eye"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.clae.2015.04.004","type":"journal-article","created":{"date-parts":[[2015,5,5]],"date-time":"2015-05-05T09:13:08Z","timestamp":1430817188000},"page":"373-378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Treatment of Sj\u00f6gren's syndrome dry eye using 0.03% tacrolimus eye drop: Prospective double-blind randomized study"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4441-4304","authenticated-orcid":false,"given":"Bernardo Kaplan","family":"Moscovici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Holzchuh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Eiji","family":"Sakassegawa-Naves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego Ricardo","family":"Hoshino-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos Bottene Villa","family":"Albers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth Miyuki","family":"Santo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard Yudi","family":"Hida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clae.2015.04.004_bib0235","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1590\/S0004-27492006000600032","article-title":"Sjogren's syndrome: diagnosis and treatment","volume":"69","author":"Felberg","year":"2006","journal-title":"Arq Bras Oftalmol"},{"key":"10.1016\/j.clae.2015.04.004_bib0240","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1542-0124(12)70081-2","article-title":"The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007)","volume":"5","year":"2007","journal-title":"Ocul Surf"},{"key":"10.1016\/j.clae.2015.04.004_bib0245","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1542-0124(12)70085-X","article-title":"Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007)","volume":"5","year":"2007","journal-title":"Ocul Surf"},{"key":"10.1016\/j.clae.2015.04.004_bib0250","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10384-004-0187-3","article-title":"Comparison of topical dexamethasone and topical FK506 treatment for the experimental allergic conjunctivitis model in BALB\/c mice","volume":"49","author":"Shoji","year":"2005","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.clae.2015.04.004_bib0255","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/ICO.0b013e31823f8c9b","article-title":"Clinical treatment of dry eye using 0.03% tacrolimus eye drops","volume":"31","author":"Moscovici","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.clae.2015.04.004_bib0260","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/02713680802149115","article-title":"Topical tacrolimus 0.03% ointment for intractable allergic conjunctivitis: an open-label pilot study","volume":"33","author":"Attas-Fox","year":"2008","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.clae.2015.04.004_bib0265","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1159\/000080937","article-title":"Immunomodulatory therapy in ophthalmology \u2013 is there a place for topical application?","volume":"218","author":"Bertelmann","year":"2004","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.clae.2015.04.004_bib0270","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1089\/jop.2007.0059","article-title":"Preliminary study of the effect of FK506 nanospheric-suspension eye drops on rejection of penetrating keratoplasty","volume":"24","author":"Fei","year":"2008","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.clae.2015.04.004_bib0275","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1089\/jop.2007.0086","article-title":"Absorption, distribution, and excretion of 14C-labeled tacrolimus (FK506) after a single or repeated ocular instillation in rabbits","volume":"24","author":"Fujita","year":"2008","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.clae.2015.04.004_bib0280","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1089\/jop.2007.0083","article-title":"Pharmacokinetics and tissue distribution of tacrolimus (FK506) after a single or repeated ocular instillation in rabbits","volume":"24","author":"Fujita","year":"2008","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.clae.2015.04.004_bib0285","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00417-001-0424-0","article-title":"Suppression of experimental immune-mediated blepharoconjunctivitis in Brown Norway rats by topical application of FK506","volume":"240","author":"Nishino","year":"2002","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.clae.2015.04.004_bib0290","first-page":"2737","article-title":"Ocular absorption of topically applied FK506 from liposomal and oil formulations in the rabbit eye","volume":"34","author":"Pleyer","year":"1993","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clae.2015.04.004_bib0295","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2165\/00128071-200203060-00002","article-title":"Topical noncorticosteroid immunomodulation in the treatment of atopic dermatitis","volume":"3","author":"Reitamo","year":"2002","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clae.2015.04.004_bib0300","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1067\/mai.2002.121832","article-title":"Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis","volume":"109","author":"Reitamo","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clae.2015.04.004_bib0305","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1067\/mai.2002.121831","article-title":"Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis","volume":"109","author":"Reitamo","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clae.2015.04.004_bib0310","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0014-2999(00)00592-6","article-title":"FK506 suppresses neutrophil chemoattractant production by peripheral blood mononuclear cells","volume":"403","author":"Sasakawa","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.clae.2015.04.004_bib0315","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/ICO.0b013e318159afbb","article-title":"Tacrolimus ointment 0.03% in the eye for treatment of giant papillary conjunctivitis","volume":"27","author":"Kymionis","year":"2008","journal-title":"Cornea"},{"key":"10.1016\/j.clae.2015.04.004_bib0320","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/01.ico.0000127484.46584.f6","article-title":"Treatment of atopic eyelid disease using topical tacrolimus following corticosteroid discontinuation in a patient with open-angle glaucoma","volume":"23","author":"Kymionis","year":"2004","journal-title":"Cornea"},{"key":"10.1016\/j.clae.2015.04.004_bib0325","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1089\/jop.2009.0087","article-title":"A randomized, placebo-controlled clinical trial of tacrolimus ophthalmic suspension 0.1% in severe allergic conjunctivitis","volume":"26","author":"Ohashi","year":"2010","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.clae.2015.04.004_bib0330","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-2002-26727","article-title":"Topical Fk506 in inflammatory corneal and conjunctival diseases. A pilot study","volume":"219","author":"Reinhard","year":"2002","journal-title":"Klin Monbl Augenheilkd"},{"key":"10.1016\/j.clae.2015.04.004_bib0335","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0002-9394(02)01982-7","article-title":"Topical tacrolimus treatment of atopic eyelid disease","volume":"135","author":"Rikkers","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clae.2015.04.004_bib0340","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1046\/j.1365-2222.2003.01698.x","article-title":"Effect of FK506 eye drops on late and delayed-type responses in ocular allergy models","volume":"33","author":"Sengoku","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.clae.2015.04.004_bib0345","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/112067210701700110","article-title":"Long-term follow-up of tacrolimus treatment in immune posterior uveitis","volume":"17","author":"Figueroa","year":"2007","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.clae.2015.04.004_bib0350","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.ophtha.2007.01.026","article-title":"Long-term efficacy and tolerance of tacrolimus for the treatment of uveitis","volume":"114","author":"Hogan","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clae.2015.04.004_bib0355","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/bjo.2004.051391","article-title":"Systemic FK506 improved tear secretion in dry eye associated with chronic graft versus host disease","volume":"89","author":"Aoki","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clae.2015.04.004_bib0360","first-page":"3228","article-title":"Phase II study of FK506 for allogeneic bone marrow transplantation","volume":"23","author":"Masaoka","year":"1991","journal-title":"Transplant Proc"},{"key":"10.1016\/j.clae.2015.04.004_bib0365","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/ICO.0b013e318199fa8c","article-title":"Long term use of topical tacrolimus (FK506) in high-risk penetrating keratoplasty","volume":"28","author":"Birnbaum","year":"2009","journal-title":"Cornea"},{"key":"10.1016\/j.clae.2015.04.004_bib0370","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/ICO.0b013e3181606086","article-title":"Comment on Dhaliwal JS, Mason BF, Kaufman SC. Long term use of topical tacrolimus (FK506) in high-risk penetrating keratoplasty","volume":"27","author":"Birnbaum","year":"2008","journal-title":"Cornea"},{"key":"10.1016\/j.clae.2015.04.004_bib0375","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/ICO.0b013e3181606086","article-title":"Long-term use of topical tacrolimus (FK506) in high-risk penetrating keratoplasty","volume":"27","author":"Dhaliwal","year":"2008","journal-title":"Cornea"},{"key":"10.1016\/j.clae.2015.04.004_bib0380","first-page":"901","article-title":"Use of topical FK506 in a corneal graft rejection model in Lewis rats","volume":"38","author":"Hikita","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clae.2015.04.004_bib0385","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0151-9638(06)70869-9","article-title":"Topical tacrolimus treatment for ocular cicatricial pemphigoid","volume":"133","author":"Michel","year":"2006","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.clae.2015.04.004_bib0390","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1463-5224.2005.00390.x","article-title":"Effect of topical 0.02% tacrolimus aqueous suspension on tear production in dogs with keratoconjunctivitis sicca","volume":"8","author":"Berdoulay","year":"2005","journal-title":"Vet Ophthalmol"},{"key":"10.1016\/j.clae.2015.04.004_bib0395","first-page":"1059","article-title":"Blood levels of FK506 after intramuscular and intravenous administration in dogs","volume":"21","author":"Morimoto","year":"1989","journal-title":"Transplant Proc"},{"key":"10.1016\/j.clae.2015.04.004_bib0400","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clae.2015.04.004_bib0405","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1001\/archopht.1969.00990020012003","article-title":"Diagnostic tests in the sicca syndrome","volume":"82","author":"van Bijsterveld","year":"1969","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clae.2015.04.004_bib0410","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00003226-199307000-00015","article-title":"Practical double vital staining for ocular surface evaluation","volume":"12","author":"Toda","year":"1993","journal-title":"Cornea"},{"key":"10.1016\/j.clae.2015.04.004_bib0415","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/02713689509033516","article-title":"Effects of topical FK506 on endotoxin-induced uveitis (EIU) in the Lewis rat","volume":"14","author":"Hikita","year":"1995","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.clae.2015.04.004_bib0420","first-page":"1265","article-title":"Effects of a new immunosuppressive agent, FK506, on experimental autoimmune uveoretinitis in rats","volume":"29","author":"Kawashima","year":"1988","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clae.2015.04.004_bib0425","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.7164\/antibiotics.40.1249","article-title":"FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics","volume":"40","author":"Kino","year":"1987","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.clae.2015.04.004_bib0430","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.7164\/antibiotics.40.1256","article-title":"FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro","volume":"40","author":"Kino","year":"1987","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.clae.2015.04.004_bib0435","first-page":"36","article-title":"Effect of FK-506 on human mixed lymphocyte reaction in vitro","volume":"19","author":"Kino","year":"1987","journal-title":"Transplant Proc"},{"key":"10.1016\/j.clae.2015.04.004_bib0440","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00003226-200105000-00020","article-title":"Successful treatment of dry eye in two patients with chronic graft-versus-host disease with systemic administration of FK506 and corticosteroids","volume":"20","author":"Ogawa","year":"2001","journal-title":"Cornea"},{"key":"10.1016\/j.clae.2015.04.004_bib0445","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/978-1-4615-5359-5_143","article-title":"Conjunctival impression cytology from dogs with keratoconjunctivitis sicca. Pre- and post-treatment with topical cyclosporine","volume":"438","author":"Bounous","year":"1998","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.clae.2015.04.004_bib0450","doi-asserted-by":"crossref","first-page":"688","DOI":"10.2460\/ajvr.2002.63.688","article-title":"Histologic characteristics and local cellular immunity of the gland of the third eyelid after topical ophthalmic administration of 2% cyclosporine for treatment of dogs with keratoconjunctivitis sicca","volume":"63","author":"Izci","year":"2002","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.clae.2015.04.004_bib0455","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/01.ico.0000151507.49565.6e","article-title":"Topical tacrolimus ointment for treatment of refractory anterior segment inflammatory disorders","volume":"24","author":"Joseph","year":"2005","journal-title":"Cornea"},{"key":"10.1016\/j.clae.2015.04.004_bib0460","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/sj.eye.6702367","article-title":"Tacrolimus ointment vs steroid ointment for eyelid dermatitis in patients with atopic keratoconjunctivitis","volume":"21","author":"Nivenius","year":"2007","journal-title":"Eye (Lond)"}],"container-title":["Contact Lens and Anterior Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367048415000582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367048415000582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,24]],"date-time":"2019-08-24T11:44:41Z","timestamp":1566647081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1367048415000582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S1367048415000582"],"URL":"https:\/\/doi.org\/10.1016\/j.clae.2015.04.004","relation":{},"ISSN":["1367-0484"],"issn-type":[{"value":"1367-0484","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Sj\u00f6gren's syndrome dry eye using 0.03% tacrolimus eye drop: Prospective double-blind randomized study","name":"articletitle","label":"Article Title"},{"value":"Contact Lens and Anterior Eye","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clae.2015.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 British Contact Lens Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}